KaloBios, Bay Area Company Formerly Run by Drug Price Gouger Martin Shkreli, to Appeal Nasdaq Delisting Decision - NBC Bay Area
Peninsula

Peninsula

The latest news from around the Peninsula

KaloBios, Bay Area Company Formerly Run by Drug Price Gouger Martin Shkreli, to Appeal Nasdaq Delisting Decision

    processing...

    NEWSLETTERS

    12 Ways to Effortlessly Surprise Your Friends and Co-Workers
    NBC Bay Area
    Martin Shkreli, ousted CEO of San Francisco’s KaloBios, is seen inside company headquarters in this November 2015 file photo.

    KaloBios, the biotech company formerly run by Martin Shkreli, says that it is appealing a decision by Nasdaq to delist the company from its stock market.

    South San Francisco-based KaloBios was notified last week that Nasdaq would move to delist the company's stock because of Shkreli's arrest and several other issues.

    Shkreli was charged with securities fraud earlier this month. KaloBios subsequently fired him as CEO and he resigned from its board.

    He became infamous earlier this year after another company he led, Turing Pharmaceuticals Inc., hiked the price of a life-saving drug by 5,000 percent. He resigned as CEO of Turing following his arrest.

    Shkreli Discusses 'Most Hated CEO' Title

    [BAY] Shkreli Discusses 'Most Hated CEO' Title
    Martin Shkreli, CEO of San Francisco’s KaloBios, sits down with NBC Bay Area's Scott Budman.
    (Published Tuesday, Nov. 24, 2015)

    KaloBios Pharmaceuticals Inc. said Tuesday that a hearing on its appeal to Nasdaq will take place in late February.

    Get the latest from NBC Bay Area anywhere, anytime
    • Download the App

      Available for IOS and Android